Abstract
Background: Over the last decade, the surgical approach to metastatic colorectal cancer radically changed, passing from a 'pure' surgical form to an Oncosurgical model. Nowadays we are experiencing the evolution and the more profound interaction between chemotherapy and surgery and we are facing with new and alternative surgical techniques for the treatment of liver metastases. Applying new integrated strategies (both surgical and chemotherapeutic), the overall resectability rate for patients presenting with liver colorectal metastases (CLMs) increased from 20 to 30–45%.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call